Dengue vaccine, QDENGA, Approved for Use in European Union

NewsDesk @bactiman63 Takeda announced Thursday that the European Commission (EC) granted marketing authorization for the company's dengue vaccine QDENGA(R) (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) for the prevention of dengue disease in individuals from four years of age in the European Union (EU). The approval follows the positive recommendation from the European Medicines Agency's Committee for [...]

The post Dengue vaccine, QDENGA, Approved for Use in European Union appeared first on Outbreak News Today.